David Turkaly
Stock Analyst at Citizens JMP
(0.27)
# 4,492
Out of 4,704 analysts
440
Total ratings
39.5%
Success rate
-3.7%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENOV Enovis | Maintained: Buy | $55 → $47 | $18.56 | +153.23% | 5 | Sep 2, 2026 | |
| SYK Stryker | Maintained: Buy | $440 → $400 | $303.13 | +31.96% | 22 | Aug 3, 2026 | |
| AXGN Axogen | Maintained: Buy | $50 → $55 | $48.28 | +13.92% | 31 | Jul 30, 2026 | |
| LNTH Lantheus Holdings | Maintained: Buy | $85 → $115 | $100.97 | +13.90% | 21 | May 8, 2026 | |
| MDXG MiMedx Group | Maintained: Buy | $7 → $6 | $4.57 | +31.29% | 3 | Apr 30, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Buy | $125 → $105 | $98.07 | +7.07% | 29 | Apr 29, 2026 | |
| TELA TELA Bio | Maintained: Buy | $5 → $3 | $0.8215 | +265.19% | 23 | Mar 27, 2026 | |
| APYX Apyx Medical | Upgraded: Buy | $8 | $3.05 | +162.30% | 34 | Nov 12, 2025 | |
| KIDS OrthoPediatrics | Maintained: Buy | $35 → $25 | $22.41 | +11.56% | 37 | Oct 10, 2025 | |
| GMED Globus Medical | Reiterated: Hold | n/a | $78.29 | n/a | 24 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $16.72 | n/a | 31 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.88 | n/a | 23 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $102.92 | n/a | 33 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $265 → $280 | $224.59 | n/a | 40 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $18.50 | n/a | 22 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $138.36 | n/a | 24 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.29 | n/a | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.21 | n/a | 10 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $70.88 | n/a | 1 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.75 | n/a | 2 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $9.64 | n/a | 1 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.48 | n/a | 1 | Jun 25, 2009 |
Enovis
Sep 2, 2026
Maintained: Buy
Price Target: $55 → $47
Current: $18.56
Upside: +153.23%
Stryker
Aug 3, 2026
Maintained: Buy
Price Target: $440 → $400
Current: $303.13
Upside: +31.96%
Axogen
Jul 30, 2026
Maintained: Buy
Price Target: $50 → $55
Current: $48.28
Upside: +13.92%
Lantheus Holdings
May 8, 2026
Maintained: Buy
Price Target: $85 → $115
Current: $100.97
Upside: +13.90%
MiMedx Group
Apr 30, 2026
Maintained: Buy
Price Target: $7 → $6
Current: $4.57
Upside: +31.29%
Zimmer Biomet Holdings
Apr 29, 2026
Maintained: Buy
Price Target: $125 → $105
Current: $98.07
Upside: +7.07%
TELA Bio
Mar 27, 2026
Maintained: Buy
Price Target: $5 → $3
Current: $0.8215
Upside: +265.19%
Apyx Medical
Nov 12, 2025
Upgraded: Buy
Price Target: $8
Current: $3.05
Upside: +162.30%
OrthoPediatrics
Oct 10, 2025
Maintained: Buy
Price Target: $35 → $25
Current: $22.41
Upside: +11.56%
Globus Medical
Aug 20, 2025
Reiterated: Hold
Price Target: n/a
Current: $78.29
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: $25
Current: $16.72
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: $7
Current: $2.88
Upside: n/a
May 20, 2025
Reiterated: Buy
Price Target: $100
Current: $102.92
Upside: n/a
May 16, 2025
Reiterated: Buy
Price Target: $265 → $280
Current: $224.59
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $32
Current: $18.50
Upside: n/a
Apr 2, 2025
Reiterated: Hold
Price Target: n/a
Current: $138.36
Upside: n/a
Mar 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.29
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $9.21
Upside: n/a
Jun 3, 2016
Reiterated: Hold
Price Target: n/a
Current: $70.88
Upside: n/a
Jun 3, 2016
Reiterated: Hold
Price Target: n/a
Current: $9.75
Upside: n/a
Jun 3, 2016
Reiterated: Buy
Price Target: $17
Current: $9.64
Upside: n/a
Jun 25, 2009
Downgraded: Hold
Price Target: n/a
Current: $3.48
Upside: n/a